Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

83
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
83
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

141
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
141
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

96
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
96
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

97
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
97
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

93
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
93
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

100
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
100

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Potassium <i>tert</i>-Butoxide-Mediated Isomerization of Alkenes: A Versatile Protocol for Miscellaneous Substrates.

ACS omega·2026
Same author

Phthalimide Derivatives as Anti-Inflammatory Agents: In Silico COX-2 Targeting and In Vitro Inhibition of PGE<sub>2</sub> Production.

Pharmaceutics·2026
Same author

Four-Step Synthesis of 3-Allyl-2-(allyloxy)-5-bromoaniline from 2-Allylphenol.

Molbank·2025
Same author

Catalyst to cure: applications of a new copper-based nanocatalyst in organic synthesis and cancer treatment.

Chemical communications (Cambridge, England)·2024
Same author

Aqueous Extracts of <i>Rhus trilobata</i> Inhibit the Lipopolysaccharide-Induced Inflammatory Response In Vitro and In Vivo.

Plants (Basel, Switzerland)·2024
Same author

Production and Physicochemical Characterization of the Gel Obtained in the Fermentation Process of Blue Corn Flour (<i>Zea mays</i> L.) with <i>Colletotrichum gloeosporioides</i>.

Gels (Basel, Switzerland)·2024

相关实验视频

Updated: May 7, 2025

Preparation of N-2-alkoxyvinylsulfonamides from N-tosyl-1,2,3-triazoles and Subsequent Conversion to Substituted Phthalans and Phenethylamines
10:42

Preparation of N-2-alkoxyvinylsulfonamides from N-tosyl-1,2,3-triazoles and Subsequent Conversion to Substituted Phthalans and Phenethylamines

Published on: January 3, 2018

9.6K

聚胺作为抗炎药物的作用

Hector Mario Heras Martinez1,2, Enrique Barragan1, Kostiantyn O Marichev3

  • 1Department of Chemistry & Physics, Florida Gulf Coast University, Fort Myers, FL, USA.

Future medicinal chemistry
|December 31, 2024
PubMed
概括
此摘要是机器生成的。

聚胺衍生物具有显著的抗炎和抗癌特性. 本综述强调了它们的合成和抗炎应用,重点关注像LASSBio 468.8这样有前途的候选药物.

关键词:
甲胺的使用方法这是一种抗炎药物.停靠的对接方式edemema edem 胀 胀 胀 在 胀 胀鼠标 鼠标 鼠标 鼠标综合合成是一种合成.

更多相关视频

Collection of Alfalfa Root Exudates to Study the Impact of Di2-ethylhexyl Phthalate on Metabolite Production
06:46

Collection of Alfalfa Root Exudates to Study the Impact of Di2-ethylhexyl Phthalate on Metabolite Production

Published on: June 2, 2023

1.6K
2-Methacryloyloxyethyl Phosphorylcholine Polymer Treatment of Complete Dentures to Inhibit Denture Plaque Deposition
06:02

2-Methacryloyloxyethyl Phosphorylcholine Polymer Treatment of Complete Dentures to Inhibit Denture Plaque Deposition

Published on: December 26, 2016

10.3K

相关实验视频

Last Updated: May 7, 2025

Preparation of N-2-alkoxyvinylsulfonamides from N-tosyl-1,2,3-triazoles and Subsequent Conversion to Substituted Phthalans and Phenethylamines
10:42

Preparation of N-2-alkoxyvinylsulfonamides from N-tosyl-1,2,3-triazoles and Subsequent Conversion to Substituted Phthalans and Phenethylamines

Published on: January 3, 2018

9.6K
Collection of Alfalfa Root Exudates to Study the Impact of Di2-ethylhexyl Phthalate on Metabolite Production
06:46

Collection of Alfalfa Root Exudates to Study the Impact of Di2-ethylhexyl Phthalate on Metabolite Production

Published on: June 2, 2023

1.6K
2-Methacryloyloxyethyl Phosphorylcholine Polymer Treatment of Complete Dentures to Inhibit Denture Plaque Deposition
06:02

2-Methacryloyloxyethyl Phosphorylcholine Polymer Treatment of Complete Dentures to Inhibit Denture Plaque Deposition

Published on: December 26, 2016

10.3K

科学领域:

  • 药用化学 医学化学
  • 有机合成 有机合成
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 异印oline-1,3-dione (phthalimide) 衍生物被认为是有价值的药物.
  • 胺具有显著的生物活性,特别是作为抗癌和抗炎药物.
  • 聚胺的结构多功能性导致了众多候选药物的开发.

研究的目的:

  • 审查用于phthalimide衍生物的合成方法.
  • 为了探索报告的甲胺化合物的抗炎活性.
  • 突出治疗开发的富他胺基候选药物的前景.

主要方法:

  • 传统合成路径的审查,包括甲酸与氨基酸/氨酸和加布里埃尔合成的反应.
  • 对各种利胺衍生物的抗炎性研究的文献数据的分析.
  • 识别和讨论具有治疗潜力的关键胺衍生物.

主要成果:

  • 已建立的合成协议可以访问多种类型的phthalimide结构.
  • 几种甲胺衍生物显示出强大的抗炎作用.
  • 在商业上可用的药物 (thalidomide,pomalidomide,lenalidomide) 和新型化合物 (LASSBio 468, adducts 2, 9, 150, 241, 255, 305) 显示出治疗的希望.

结论:

  • 聚胺衍生物是具有显著抗炎和抗癌潜力的化合物的丰富来源.
  • 优化的合成策略有助于探索新型的胺类类似物.
  • 对于发现新的治疗药物而言,对甲胺衍生物的持续研究至关重要.